Obulytix is a biotech spin-off focused on developing Precision Lysin Therapeutics (PLTs), a new class of targeted biologics designed to selectively kill bacteria without fueling antimicrobial resistance
Obulytix is a biotech spin-off focused on developing Precision Lysin Therapeutics (PLTs), a new class of targeted biologics designed to selectively kill bacteria without fueling antimicrobial resistance. The company utilizes artificial intelligence to enhance the development of its innovative antibiotic therapies.